Filing Details
- Accession Number:
- 0001415889-23-000171
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-03 21:23:11
- Reporting Period:
- 2022-12-30
- Accepted Time:
- 2023-01-03 21:23:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682639 | Eyenovia Inc. | EYEN | Pharmaceutical Preparations (2834) | 471178401 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744774 | M Michael Rowe | C/O Eyenovia, Inc. 295 Madison Avenue, Suite 2400 New York NY 10017 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 | Acquisiton | 2022-12-30 | 10,000 | $1.54 | 15,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.55. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Billionaire Hedge Funds
